Alberti KG. 2000. Multicentre research ethics committees: Has the cure been worse than the disease? No, but idiosyncracies and obstructions to good research must be removed. British Medical Journal 320(7243):1157–1158.

Altman D. 2002. Poor-Quality Medical Research: What Can Journals Do? JAMA 287(21):2869–2871.

Amdur RJ. 2000. Improving the Protection of Human Research Subjects. Academic Medicine 75(7):718–720.

Andejeski et al. 2002. Quantitative impact of including consumers in the scientific review of breast cancer research proposals. Journal of Women’s Health and Gender-Based Medicine 11(4):351–360.

Anderson D, Costa I, Dickersin K. Forthcoming. Building Trials Central, an online register of clinical trials registers. Controlled Clinical Trials.

Angell M. 2000. Presentation at the August 15-16, 2000, Conference on Human Subject Protection and Financial Conflicts of Interest, National Institutes of Health, Bethesda, MD.

Annas GJ. 1991. Ethics Committees: From Ethical Comfort to Ethical Cover. Hastings Center Report 21(3):18–21.

Annas GJ and Grodin M. 1992. The Nazi Doctors and the Nuremberg Code: Human Rights in Human Experimentation. Oxford: Oxford University Press.

Annas, et al. 1977. Compensation for Harm: An Additional Protection for Human Subjects. In: Informed Consent: The Subject’s Dilemma. Cambridge, MA: Ballinger Publishing Company. Pp. 257–277.

Antman EM, et al. 1992. A Comparison of Results of Meta-analyses of Randomized Control Trials and Recommendations of Clinical Experts: Treatments for Myocardial Infarction. JAMA 268(2):240–247.

Appelbaum PS, Roth LH, Lidz C. 1982. The therapeutic misconception: Informed consent in psychiatric research. International Journal of Law and Psychiatry 5(3-4):319–329.

Argetsinger A. 2001, October 27. Smallpox Vaccine Studies Swamped with Volunteers. The Washington Post. p. B1.

ASGT (American Society of Gene Therapy). 2000. Policy of the American Society of Gene Therapy on Financial Conflict of Interest in Clinical Research. [Online]. Available: http://www.asgt.org/policy/index.html [accessed December 28, 2001].

Atkinson HG. 2000. Decision-making dialogue. Health News 6(2):4–5.


Barnbaum D. 2002. Making More Sense of “Minimal Risk.” IRB: Ethics and Human Research 24(3):10–13.

Bastian H. 1994. The Power of Sharing Knowledge: Consumer Participation in the Cochrane Collaboration. [Online]. Available: http://www.cochraneconsumer.com/p_Involve.asp [accessed August 14, 2002].

Batt S. 1994. Patient No More: The Politics of Breast Cancer. Canada: Gynergy Books.

Bazell R. 1998. HER-2: The Making of Herception, a Revolutionary Treatment for Breast Cancer. New York City: Random House.

Beecher HK. 1966. Ethics and Clinical Research. New England Journal of Medicine 274(24): 1354–1360.

Bell J, et al. 1998. Prepared for the Office of Extramural Research, NIH. Evaluation of NIH Implementation of Section 491 of the Public Health Service Act, Mandating a Program of Protection for Research Subjects. Alexandria, VA: James Bell and Associates.

Benson PR, et al. 1988. Information Disclosure, Subject Understanding, and Informed Consent in Psychiatric Research. Law and Human Behavior 12(4):455–475.

Berwick DM. 1990. Peer review and quality management: Are they compatible. Quality Review Bulletin 16(7):246–251.

Blumenstyk G. 2002, January 11. Crusader for the Rights of Research Volunteers. The Chronicle of Higher Education. p. A34.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement